European Medical Journal 3.4 2018

| View in Fullscreen

In this issue

Volume 3, Issue 4 Contents

Page Numbers Title Authors
Feature
10-15 The Lancet Asthma Commission: Towards the Abolition of Asthma? Andy Bush, Ian D. Pavord
Symposium Reviews
16-22 Translating Knowledge of IL-23 Targeting into New Solutions for Psoriasis Treatment Lorena Tonarelli
24-33 Type 2 Inflammation and the Evolving Profile of Uncontrolled Persistent Asthma Helen Saul
34-39 Management of Fluctuating Parkinson’s Disease: From Science to Clinical Wisdom Anita Chadha-Patel
Articles
40-48 Editor’s Pick: Newest Approaches in Immunotherapy for Non-Hodgkin’s Lymphoma Emily C. Ayers, Sunita D. Nasta
50-61 iBiopsy® for Precision Medicine Brag et al.
62-69 Liposomal-Glutathione as a Potential Therapeutic Agent to Control HIV-1 Infection and Tuberculosis Robinson et al.
70-78 From Renal Biomarkers to Therapeutic Targets: The Use of Monocyte Chemoattractant Protein 1, Transforming Growth Factor-Beta, and Connective Tissue Growth Factor in Diabetic Nephropathy and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Katrina J Spensley, Frederick W. K. Tam
79-86 Central Processes Underlying Fibromyalgia Geoffrey Littlejohn, Emma Guymer
87-94 Customised Oocyte Donation Enhancement and New Findings Regarding the Role of Growth Hormone Jan Tesarik
95-102 Chronic Spontaneous Urticaria in Patients with Common Variable Immunodeficiency Frossi et al.
103-110 Drilling Down to the Bone: Evaluating Bone Marrow Lesions in Osteoarthritis Nidhi Sofat
111-121 Asthma: Diagnosis and Treatment So et al.
122-129 Genetic Associations and Environmental Exposures in the Aetiopathogenesis of Anti-Neutrophil Cytoplasmic Antibody- Associated Vasculitis: An Updated Review Maurizio Salvadori, Aris Tsalouchos
130-137 Effect of Mesenchymal Stem Cells in Autoimmune Arthritis Fan Yang, Yang Li